FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891068637> ?p ?o ?g. }

• W2891068637 endingPage "708" @default.
• W2891068637 startingPage "702" @default.
• W2891068637 abstract "In equines, Cr2O3 is widely accepted as an indigestible marker, but there are health concerns regarding the carcinogenic properties of Cr2O3. Recently, TiO2 has been suggested to be an alternative digestibility marker in equines. However, a comparison between Cr2O3 and TiO2 has not been made in equines. Six Welsh pony geldings (initial BW: 254±3 kg; 7 years of age) fed chopped alfalfa hay were used to evaluate the use of TiO2 (Ti) and Cr2O3 (Cr) as markers for calculating apparent digestibility and to investigate the effect of frequency of marker administration on the measurement of digestibility values. Diets contained 4.65 kg dry matter (DM) chopped alfalfa hay supplemented with minerals, vitamins, TiO2 (3.3 g Ti/day) and Cr2O3 (3.2 g Cr/day). Ponies were dosed with either 3.3 g Ti and 3.2 g Cr once daily (DF1) or with 1.65 g Ti and 1.60 g Cr twice daily (DF2). After adaptation to the diets and procedures for 14 days, voluntary voided faeces were collected quantitatively over 7 days and analysed for moisture, ash, Ti and Cr. Apparent total tract DM digestibility (DMD) and organic matter digestibility (OMD) were calculated using the total faecal collection (TFC) and marker method (Ti and Cr). The overall mean cumulative faecal recovery of Cr and Ti (as % of intake) were 102.0% and 96.6%, respectively. Mean daily faecal recoveries of Cr as well as of Ti were not different (P=0.323; P=0.808, respectively) between treatments. Overall daily faecal recovery of Cr differed (P=0.019) from 100% when the marker was dosed once daily, whereas overall daily faecal recovery was similar to 100% for both administration frequencies when Ti was used as a marker. For both markers, the coefficient of variation of the mean faecal marker recovery between horses was lower when the markers were administrated twice per day. Across treatments, cumulative DMD and OMD estimated with Ti were similar (P=0.345; P=0.418, respectively) compared with those values determined by TFC method. When Cr was used, the calculated cumulative DMD tended (P=0.097) to be greater compared with those estimated with TFC, and cumulative OMD values were overestimated (P=0.013). Orally supplemented Ti recovery in the faeces of ponies fed chopped alfalfa hay with Ti administered once or twice daily was close to 100%, making it the preferred marker for digestibility trials in equines." @default.
• W2891068637 created "2018-09-27" @default.
• W2891068637 creator A5008456514 @default.
• W2891068637 creator A5009285316 @default.
• W2891068637 creator A5019642211 @default.
• W2891068637 creator A5026749195 @default.
• W2891068637 creator A5034019060 @default.
• W2891068637 creator A5044007423 @default.
• W2891068637 creator A5064730734 @default.
• W2891068637 date "2019-01-01" @default.
• W2891068637 modified "2023-09-27" @default.
• W2891068637 title "Evaluation of titanium dioxide and chromic oxide as digestibility markers in ponies fed alfalfa hay in relation to marker dosing frequency" @default.
• W2891068637 cites W108341821 @default.
• W2891068637 cites W1997087247 @default.
• W2891068637 cites W2010483959 @default.
• W2891068637 cites W2011373703 @default.
• W2891068637 cites W2037902005 @default.
• W2891068637 cites W2044200970 @default.
• W2891068637 cites W2045374242 @default.
• W2891068637 cites W2054263655 @default.
• W2891068637 cites W2060905813 @default.
• W2891068637 cites W2066528863 @default.
• W2891068637 cites W2073556289 @default.
• W2891068637 cites W2074513481 @default.
• W2891068637 cites W2086541077 @default.
• W2891068637 cites W2111933331 @default.
• W2891068637 cites W2122819770 @default.
• W2891068637 cites W2145938131 @default.
• W2891068637 cites W2152688447 @default.
• W2891068637 cites W2156766862 @default.
• W2891068637 cites W2166795541 @default.
• W2891068637 cites W2187589528 @default.
• W2891068637 cites W2206249322 @default.
• W2891068637 cites W2341023563 @default.
• W2891068637 cites W2408634389 @default.
• W2891068637 cites W2415810370 @default.
• W2891068637 cites W2606403539 @default.
• W2891068637 cites W54705769 @default.
• W2891068637 cites W84084948 @default.
• W2891068637 doi "https://doi.org/10.1017/s1751731118002112" @default.
• W2891068637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30175695" @default.
• W2891068637 hasPublicationYear "2019" @default.
• W2891068637 type Work @default.
• W2891068637 sameAs 2891068637 @default.
• W2891068637 citedByCount "4" @default.
• W2891068637 countsByYear W28910686372019 @default.
• W2891068637 countsByYear W28910686372021 @default.
• W2891068637 countsByYear W28910686372022 @default.
• W2891068637 crossrefType "journal-article" @default.
• W2891068637 hasAuthorship W2891068637A5008456514 @default.
• W2891068637 hasAuthorship W2891068637A5009285316 @default.
• W2891068637 hasAuthorship W2891068637A5019642211 @default.
• W2891068637 hasAuthorship W2891068637A5026749195 @default.
• W2891068637 hasAuthorship W2891068637A5034019060 @default.
• W2891068637 hasAuthorship W2891068637A5044007423 @default.
• W2891068637 hasAuthorship W2891068637A5064730734 @default.
• W2891068637 hasBestOaLocation W28910686371 @default.
• W2891068637 hasConcept C100544194 @default.
• W2891068637 hasConcept C106191032 @default.
• W2891068637 hasConcept C140793950 @default.
• W2891068637 hasConcept C151730666 @default.
• W2891068637 hasConcept C178790620 @default.
• W2891068637 hasConcept C185592680 @default.
• W2891068637 hasConcept C2780138947 @default.
• W2891068637 hasConcept C2780762169 @default.
• W2891068637 hasConcept C2781413975 @default.
• W2891068637 hasConcept C2909466429 @default.
• W2891068637 hasConcept C3018814304 @default.
• W2891068637 hasConcept C31903555 @default.
• W2891068637 hasConcept C48743137 @default.
• W2891068637 hasConcept C54355233 @default.
• W2891068637 hasConcept C61716771 @default.
• W2891068637 hasConcept C70262065 @default.
• W2891068637 hasConcept C86803240 @default.
• W2891068637 hasConceptScore W2891068637C100544194 @default.
• W2891068637 hasConceptScore W2891068637C106191032 @default.
• W2891068637 hasConceptScore W2891068637C140793950 @default.
• W2891068637 hasConceptScore W2891068637C151730666 @default.
• W2891068637 hasConceptScore W2891068637C178790620 @default.
• W2891068637 hasConceptScore W2891068637C185592680 @default.
• W2891068637 hasConceptScore W2891068637C2780138947 @default.
• W2891068637 hasConceptScore W2891068637C2780762169 @default.
• W2891068637 hasConceptScore W2891068637C2781413975 @default.
• W2891068637 hasConceptScore W2891068637C2909466429 @default.
• W2891068637 hasConceptScore W2891068637C3018814304 @default.
• W2891068637 hasConceptScore W2891068637C31903555 @default.
• W2891068637 hasConceptScore W2891068637C48743137 @default.
• W2891068637 hasConceptScore W2891068637C54355233 @default.
• W2891068637 hasConceptScore W2891068637C61716771 @default.
• W2891068637 hasConceptScore W2891068637C70262065 @default.
• W2891068637 hasConceptScore W2891068637C86803240 @default.
• W2891068637 hasIssue "4" @default.
• W2891068637 hasLocation W28910686371 @default.
• W2891068637 hasLocation W28910686372 @default.
• W2891068637 hasOpenAccess W2891068637 @default.
• W2891068637 hasPrimaryLocation W28910686371 @default.
• W2891068637 hasRelatedWork W2005608141 @default.
• W2891068637 hasRelatedWork W2062628461 @default.

• next